HDAC inhibitors in experimental liver and kidney fibrosis

Histone deacetylase (HDAC) inhibitors have been extensively studied in experimental models of cancer, where their inhibition of deacetylation has been proven to regulate cell survival, proliferation, differentiation and apoptosis. This in turn has led to the use of a variety of HDAC inhibitors in cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Beneden, Katrien, Mannaerts, Inge, Pauwels, Marina, Van den Branden, Christiane, van Grunsven, Leo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564760/
https://www.ncbi.nlm.nih.gov/pubmed/23281659
http://dx.doi.org/10.1186/1755-1536-6-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3564760/
https://www.ncbi.nlm.nih.gov/pubmed/23281659
http://dx.doi.org/10.1186/1755-1536-6-1

Ejemplares similares